Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Horizon Therapeutics plc
About
  2. Companies
  3. Horizon Therapeutics plc
  4. Products
  5. Horizon - Model TEPEZZA - Monoclonal ...

Horizon - Model TEPEZZA -Monoclonal Antibody

SHARE

A monoclonal antibody against insulin-like growth factor-1 receptor (IGF-1R). TED in Japan (OPTIC-J): Phase 3 randomized, placebo-controlled trial in Japan to evaluate TEPEZZA in patients with moderate-to-severe active TED.

Most popular related searches
monoclonal antibody
pharmacokinetic

Diffuse Cutaneous Systemic Sclerosis: Phase 1 trial exploring TEPEZZA in diffuse cutaneous systemic sclerosis.

Subcutaneous Administration: Phase 1 pharmacokinetic trial to explore subcutaneous administration of TEPEZZA.